Coya Therapeutics reported cash from operations of -$7.38M and free cash flow of -$7.38M for the quarter ended Jun 2026, down 27.8% year over year. This cash flow statement covers 19 quarters of results from Dec 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||
| Net Income | -1.70M | -3.45M | -2.66M | -2.00M | -2.90M | -3.25M | -3.56M | 1.82M | -5.05M | -2.89M | -4.45M | -4.08M | -7.31M | -6.09M | -2.43M | -6.03M | -7.21M | -6.64M | |
| Share-based CompensationStock Comp. | 0.36M | 0.02M | 0.04M | 0.07M | 0.07M | 1.01M | 1.13M | 1.24M | 0.24M | 1.70M | 2.20M | 2.23M | 0.79M | 3.06M | 2.96M | 6.40M | 1.10M | 7.30M | 5.40M |
| Cash from OperationsCash from Ops. | -1.98M | -1.44M | -1.59M | -2.22M | -3.86M | -2.87M | -2.22M | -2.24M | 2.15M | -4.56M | -5.46M | -2.41M | -2.83M | -5.77M | -1.13M | -1.01M | -6.21M | -7.38M | |
| Change in Working Capital | |||||||||||||||||||
| Change in Account PayablesChange Payables | -0.37M | 0.77M | 0.05M | 0.39M | -0.27M | -0.30M | 0.40M | 0.48M | 0.48M | 0.24M | -1.49M | 1.25M | 0.10M | -0.76M | 0.18M | -0.05M | -0.15M | 0.06M | |
| Change in Accured ExpensesChange Accured Exp. | -0.13M | 0.17M | 0.69M | 0.10M | -1.28M | 0.26M | 0.19M | 1.71M | -0.84M | -1.04M | 0.41M | -0.02M | 0.42M | 1.03M | -1.20M | 0.85M | -1.38M | -0.16M | |
| Investing Activities | |||||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | -0.39M | -0.19M | -0.03M | -0.65M | -0.89M | -0.00M | |||||||||||||
| Financing Activities | |||||||||||||||||||
| Other financing activitiesOther financing | 158.00 | 14.25M | 1.36M | 0.15M | 0.63M | 0.02M | 0.02M | ||||||||||||
| Cash from Financing ActivitiesCash from Financing | -0.07M | 9.54M | -0.01M | -0.10M | 14.25M | 24.17M | 1.24M | 5.15M | -0.06M | 9.69M | 0.02M | 0.02M | 20.35M | 11.00M | -0.17M | ||||
| Change in Capital Stock | |||||||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 0.15M | 0.54M | 0.76M | 0.57M | 1.10M | 0.85M | 0.92M | 0.89M | |||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | -0.06M | 9.06M | 11.00M | -0.04M | |||||||||||||||
| Additional items | |||||||||||||||||||
| Change in Cash | -2.05M | 8.10M | -1.74M | -2.72M | 10.39M | -3.22M | -2.22M | 21.74M | 3.36M | 0.59M | -5.52M | 7.28M | -2.81M | -5.77M | -1.63M | 18.69M | 3.90M | -7.54M | |
| Free Cash FlowFCF | -1.98M | -1.44M | -1.59M | -2.22M | -3.86M | -2.87M | -2.22M | -2.24M | 2.15M | -4.56M | -5.46M | -2.41M | -2.83M | -5.77M | -1.13M | -1.01M | -6.21M | -7.38M | |
| Net Cash FlowNCF | -2.05M | 8.10M | -1.60M | -2.72M | 10.39M | -2.87M | -2.22M | 21.74M | 3.36M | 0.59M | -5.52M | 7.28M | -2.81M | -5.77M | -1.11M | 18.69M | 3.90M | -7.54M |